Filter Results:
(6,304)
Show Results For
- All HBS Web
(6,304)
- People (3)
- News (1,207)
- Research (4,500)
- Events (35)
- Multimedia (67)
- Faculty Publications (2,930)
Show Results For
- All HBS Web
(6,304)
- People (3)
- News (1,207)
- Research (4,500)
- Events (35)
- Multimedia (67)
- Faculty Publications (2,930)
- 06 Mar 2012
- News
America's industrial policy
- 2007
- Other Unpublished Work
Influence and Inefficiency in the Internal Capital Market
By: Julie Wulf
I model inefficient resource allocations in M-form organizations due to influence activities by division managers that skew capital budgets in their favor. Corporate headquarters receives two types of signals about investment opportunities: private signals that can be... View Details
Joseph B. Fuller
Joseph Fuller is a Professor of Management Practice in General Management and Entrepreneurship. He founded and co-leads the school’s project, Managing the Future of Work, as well as the Harvard Project on the Workforce. He currently leads the FIELD Global Capstone... View Details
- December 2019
- Case
Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem (Abridged)
By: Willy Shih
This case describes the efforts of the Bill & Melinda Gates Foundation to lower the cost of producing vaccines to prevent polio infections. It is an abridged version of HBS Case No. 620-021 with less emphasis on comparison between traditional and the new compact... View Details
Keywords: Vaccine; Manufacturing; Barriers To Entry; Production; Cost; Technological Innovation; Market Entry and Exit; Pharmaceutical Industry
Shih, Willy. "Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem (Abridged)." Harvard Business School Case 620-071, December 2019.
- November 2022
- Article
Opportunity Neglect: An Aversion to Low-probability Gains
By: Emily Prinsloo, Kate Barasz, Leslie K. John and Michael I. Norton
Seven preregistered studies (N = 2,890) conducted in the field, lab, and online document opportunity neglect: a tendency to reject opportunities with low probability of success, even when they come with little or no objective cost (e.g., time, money,... View Details
Prinsloo, Emily, Kate Barasz, Leslie K. John, and Michael I. Norton. "Opportunity Neglect: An Aversion to Low-probability Gains." Psychological Science 33, no. 11 (November 2022): 1857–1866.
- 26 Jan 2019
- Working Paper Summaries
Marketplace Scalability and Strategic Use of Platform Investment
Keywords: by Jin Li, Gary P. Pisano, and Feng Zhu
- February 1992 (Revised July 1992)
- Background Note
Note on Cross-Border Valuation
By: W. Carl Kester and Julia Morley
Provides a fundamental technical review of valuation techniques used to assess cross-border investments. Discusses the discounting of free cash flows with a weighted average cost of capital, the use of adjusted present value, and the importance of considering real... View Details
Kester, W. Carl, and Julia Morley. "Note on Cross-Border Valuation." Harvard Business School Background Note 292-084, February 1992. (Revised July 1992.)
- February 2010
- Case
Saginaw Parts Co. and the General Motors Corp. Credit Default Swap
This two-page case demonstrates how to unbundle the cost of credit extensions from product prices by observing the price of a credit default swap. It also explores how credit default swaps work, and how trade creditors are treated under U.S. bankruptcy law. Finally it... View Details
Keywords: Trade; Credit; Insolvency and Bankruptcy; Credit Derivatives and Swaps; Laws and Statutes; Risk Management; Auto Industry; United States
Fruhan, William E. "Saginaw Parts Co. and the General Motors Corp. Credit Default Swap." Harvard Business School Case 210-056, February 2010.
- 02 Jan 2024
- Research & Ideas
10 Trends to Watch in 2024
The lightning-fast ascent of generative AI isn’t the only sea change on the horizon for businesses in the new year. The global economy is in flux as war, climate change, trade issues, and infrastructure problems demand attention. Many companies continue to struggle to... View Details
Keywords: by Rachel Layne
- March 1994 (Revised April 1994)
- Case
Eli Lilly and Co.: The Flexible Facility Decision--1993
By: Gary P. Pisano
In 1993, Eli Lilly is preparing to build manufacturing capacity for three new pharmaceutical products that it expects to launch in 1996. Management wrestles with a decision of whether to add specialized manufacturing capacity or flexible capacity. This question touches... View Details
Keywords: Debates; Cost vs Benefits; Decisions; Investment; Goals and Objectives; Product Launch; Production; Corporate Strategy; Pharmaceutical Industry
Pisano, Gary P. "Eli Lilly and Co.: The Flexible Facility Decision--1993." Harvard Business School Case 694-074, March 1994. (Revised April 1994.)
- May 2012
- Case
Westlake Lanes: How Can This Business Be Saved?
By: Richard G. Hamermesh and Alisa Zalosh
Shelby Givens, a new MBA, is the general manager of Westlake Lanes, a near-bankrupt bowling alley that her grandfather founded decades earlier. Givens has been given one year to turn a profit; if the goal is not met Westlake will close. During the first few days on the... View Details
Keywords: United States; Operations Management; Small And Medium-sized Enterprises; Turnarounds; Strategy; Leading Change; Marketing Strategy; Entrepreneurship; Operations; Transformation; Growth and Development Strategy; Entertainment and Recreation Industry; United States
Hamermesh, Richard G., and Alisa Zalosh. "Westlake Lanes: How Can This Business Be Saved?" Harvard Business School Brief Case 124-431, May 2012.
- 15 Sep 2017
- Working Paper Summaries
Debt Redemption and Reserve Accumulation
Keywords: by Laura Alfaro and Fabio Kanczuk
- March 2014
- Technical Note
Drivers of Value Creation
This note introduces a concise but comprehensive framework for analyzing value creation and value creation advantage, i.e., a firm's superior ability to increase the spread (or gap) between its offering's customer value (or WTP) and supplier cost (or WTS). (While the... View Details
Van den Steen, Eric. "Drivers of Value Creation." Harvard Business School Technical Note 714-487, March 2014.
- 09 Aug 2013
- News
What is it about healthcare costs?
Location Choices under Strategic Interactions
The literature on location choices has mostly emphasized the impact of location and firm characteristics. However, most industries with a significant presence of multi-location firms are oligopolistic in nature, which suggests that strategic interaction among firms... View Details
- Article
Accounting for Climate Change
By: Robert S. Kaplan and Karthik Ramanna
Corporations are facing growing pressure—from investors, advocacy groups, politicians, and even business leaders themselves—to reduce greenhouse gas (GHG) emissions from their operations and their supply and distribution chains. About 90% of the companies in the S&P... View Details
Keywords: Greenhouse Gas Mitigation; Social Accounting; E-liabilities; Business And The Environment; Climate Change; Corporate Social Responsibility and Impact; Environmental Sustainability
Kaplan, Robert S., and Karthik Ramanna. "Accounting for Climate Change." Harvard Business Review 99, no. 6 (November–December 2021): 120–131.
- March 1990 (Revised October 1999)
- Case
Mary Kay Cosmetics: Sales Force Incentives (A)
By: Robert L. Simons and Hilary Weston
Describes the incentive system by which Mary Kay Cosmetics motivates the sales force of 200,000 independent agents who comprise the firm's only distribution channel. Illustrates the powerful effect on sales-force behavior that results when creative types of employee... View Details
Keywords: Motivation and Incentives; Cost Management; Salesforce Management; Distribution Channels; Beauty and Cosmetics Industry; United States
Simons, Robert L., and Hilary Weston. "Mary Kay Cosmetics: Sales Force Incentives (A)." Harvard Business School Case 190-103, March 1990. (Revised October 1999.)
- September 2014 (Revised February 2015)
- Case
Pfizer and AstraZeneca: Marketing an Acquisition (A)
By: John A. Quelch and James Weber
In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to... View Details
Keywords: Health Care Policy; Mergers And Acquisitions; Marketing; Government Relations; Crisis Management; Decision Making; Growth and Development; Management; Markets; Strategy; Pharmaceutical Industry; United Kingdom; United States
Quelch, John A., and James Weber. "Pfizer and AstraZeneca: Marketing an Acquisition (A)." Harvard Business School Case 515-007, September 2014. (Revised February 2015.)
- Article
Third-party Punishment as a Costly Signal of Trustworthiness
By: Jillian J. Jordan, Moshe Hoffman, Paul Bloom and David G. Rand
Third-party punishment (TPP), in which unaffected observers punish selfishness, promotes cooperation by deterring defection. But why should individuals choose to bear the costs of punishing? We present a game theoretic model of TPP as a costly signal of... View Details
Jordan, Jillian J., Moshe Hoffman, Paul Bloom, and David G. Rand. "Third-party Punishment as a Costly Signal of Trustworthiness." Nature 530, no. 7591 (2016): 473–476.
- 2012
- Chapter
Inflection Point: New Vision, New Strategy, New Organization
By: Nancy O. Andrews and Nicolas P. Retsinas
What does it cost to build a great society? More
pointedly, what does it cost to lose a great society?
Since the War on Poverty began almost 50 years
ago, investments in America’s communities have
spurred those questions. Today we face a society
more unequal than... View Details
Andrews, Nancy O., and Nicolas P. Retsinas. "Inflection Point: New Vision, New Strategy, New Organization." In Investing in What Works for America's Communities: Essays on People, Place & Purpose, edited by Nancy O. Andrews, David J. Erickson, Ian J. Galloway, and Ellen S. Seidman, 407–419. San Francisco, CA: Federal Reserve Bank of San Francisco, 2012.